|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
1.000
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.999
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.999
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.999
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.995
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.994
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.947
|
|
|
|
sodium ion import
|
GO:0097369 |
1 |
0.947
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.944
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.938
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.904
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.895
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.886
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.878
|
|
|
|
response to glycoside
|
GO:1903416 |
2 |
0.864
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.832
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.824
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.813
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.804
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.783
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.777
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.774
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.764
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.724
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.707
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.699
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.664
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.663
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.659
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.639
|
|
|
|
sodium ion export
|
GO:0071436 |
2 |
0.636
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.615
|
|
|
|
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0014808 |
12 |
0.581
|
|
|
|
regulation of skeletal muscle adaptation
|
GO:0014733 |
12 |
0.564
|
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.538
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.525
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.524
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.505
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.486
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.484
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.464
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.450
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.420
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.390
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.388
|
|
|
|
regulation of atp metabolic process
|
GO:1903578 |
17 |
0.386
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.384
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.377
|
|
|
|
regulation of cardiac muscle contraction by calcium ion signaling
|
GO:0010882 |
9 |
0.374
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.372
|
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.371
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.370
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.358
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.356
|
|
|
|
regulation of potassium ion transmembrane transporter activity
|
GO:1901016 |
7 |
0.354
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.342
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.330
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.321
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.311
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.308
|
|
|
|
regulation of membrane repolarization
|
GO:0060306 |
7 |
0.308
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.293
|
|
|
|
endoplasmic reticulum to cytosol transport
|
GO:1903513 |
12 |
0.291
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.289
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.289
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.281
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.279
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.267
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.259
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.248
|
|
|
|
positive regulation of ion transmembrane transporter activity
|
GO:0032414 |
15 |
0.242
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.235
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.232
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.232
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.228
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.226
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.225
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.223
|
|
|
|
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
|
GO:0010881 |
7 |
0.220
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.211
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.211
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.209
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.207
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.199
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.198
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.196
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.195
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.193
|
|
|
|
regulation of atp biosynthetic process
|
GO:2001169 |
3 |
0.192
|
|
|
|
calcium ion transport from endoplasmic reticulum to cytosol
|
GO:1903514 |
12 |
0.187
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.163
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.160
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.155
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.154
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
22 |
0.154
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.152
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.150
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.150
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.146
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.140
|
|
|
|
response to activity
|
GO:0014823 |
13 |
0.139
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.137
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.137
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.136
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.136
|
|
|
|
positive regulation of cellular respiration
|
GO:1901857 |
3 |
0.135
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.135
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.134
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.132
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.126
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.126
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.125
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.123
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.123
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.121
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.117
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.116
|
|
|
|
regulation of potassium ion transmembrane transport
|
GO:1901379 |
11 |
0.115
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.114
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.114
|
|
|
|
transition between fast and slow fiber
|
GO:0014883 |
9 |
0.112
|
|
|
|
positive regulation of transmembrane transport
|
GO:0034764 |
29 |
0.111
|
|
|
|
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0010880 |
10 |
0.110
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.108
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.105
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.105
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.104
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.103
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.101
|
|
|
|
positive regulation of atp biosynthetic process
|
GO:2001171 |
2 |
0.098
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.097
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.095
|
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
9 |
0.095
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.095
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.095
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.095
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.094
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.094
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.093
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.093
|
|
|
|
membrane repolarization
|
GO:0086009 |
7 |
0.092
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.092
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.091
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.091
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.090
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.088
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.088
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.088
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.086
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
27 |
0.084
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.082
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.081
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.080
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.080
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.079
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.078
|
|
|
|
positive regulation of potassium ion transmembrane transporter activity
|
GO:1901018 |
1 |
0.078
|
|
|
|
skeletal muscle myosin thick filament assembly
|
GO:0030241 |
1 |
0.076
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.076
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.076
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.075
|
|
|
|
positive regulation of transporter activity
|
GO:0032411 |
17 |
0.075
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.074
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.074
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.073
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.073
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.073
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.070
|
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.070
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.070
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.070
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.069
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.069
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.067
|
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
16 |
0.066
|
|
|
|
positive regulation of potassium ion transmembrane transport
|
GO:1901381 |
3 |
0.065
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.064
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.064
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.064
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.063
|
|
|
|
cellular respiration
|
GO:0045333 |
38 |
0.063
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.062
|
|
|
|
response to catecholamine
|
GO:0071869 |
4 |
0.062
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.062
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.061
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.061
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.060
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.060
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.060
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.059
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.059
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.059
|
|
|
|
regulation of ryanodine sensitive calcium release channel activity
|
GO:0060314 |
10 |
0.059
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.059
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.059
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
24 |
0.057
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.056
|
|
|
|
response to camp
|
GO:0051591 |
14 |
0.055
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.055
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.055
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.054
|
|
|
|
positive regulation of alkaline phosphatase activity
|
GO:0010694 |
3 |
0.053
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.053
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.053
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.053
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.052
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.052
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.052
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.052
|
|
|
|
galactose metabolic process
|
GO:0006012 |
4 |
0.052
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.052
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.051
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.051
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.050
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.049
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.049
|
|
|
|
relaxation of smooth muscle
|
GO:0044557 |
8 |
0.049
|
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.048
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.048
|
|
|
|
muscle filament sliding
|
GO:0030049 |
1 |
0.048
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.048
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.048
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.047
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.046
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.045
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.045
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.045
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.043
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.043
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.042
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.041
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.040
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.040
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.039
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.039
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.039
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.039
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.038
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.038
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.038
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.038
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.037
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.037
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.037
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.036
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.036
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.036
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.036
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.036
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.035
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.035
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.035
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.035
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.035
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.035
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.035
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.034
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.034
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.034
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.034
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.034
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.033
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.033
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.032
|
|
|
|
response to organophosphorus
|
GO:0046683 |
22 |
0.032
|
|
|
|
rna dependent dna replication
|
GO:0006278 |
3 |
0.032
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.032
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.031
|
|
|
|
calcium ion import
|
GO:0070509 |
14 |
0.031
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.030
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.030
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.030
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.030
|
|
|
|
regulation of n methyl d aspartate selective glutamate receptor activity
|
GO:2000310 |
10 |
0.029
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.029
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.029
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.029
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.029
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
8 |
0.028
|
|
|
|
positive regulation of phosphatase activity
|
GO:0010922 |
4 |
0.028
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.028
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.028
|
|
|
|
positive regulation of mitochondrion organization
|
GO:0010822 |
17 |
0.028
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.028
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.028
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
21 |
0.027
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.027
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.027
|
|
|
|
energy homeostasis
|
GO:0097009 |
15 |
0.027
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.027
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.027
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.027
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.027
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.026
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.026
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.026
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.026
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.026
|
|
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.026
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.026
|
|
|
|
negative regulation of smooth muscle cell migration
|
GO:0014912 |
2 |
0.026
|
|
|
|
regulation of cellular respiration
|
GO:0043457 |
10 |
0.025
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.025
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.025
|
|
|
|
actin myosin filament sliding
|
GO:0033275 |
1 |
0.025
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.025
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.024
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.024
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.024
|
|
|
|
nucleoside biosynthetic process
|
GO:0009163 |
21 |
0.024
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.024
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.024
|
|
|
|
cellular response to caffeine
|
GO:0071313 |
4 |
0.024
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.024
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.024
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.024
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.024
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.024
|
|
|
|
purine nucleoside biosynthetic process
|
GO:0042451 |
19 |
0.024
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.024
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.023
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.023
|
|
|
|
vascular smooth muscle contraction
|
GO:0014829 |
5 |
0.023
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.023
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.023
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.023
|
|
|
|
positive regulation of atpase activity
|
GO:0032781 |
3 |
0.023
|
|
|
|
purine ribonucleoside biosynthetic process
|
GO:0046129 |
19 |
0.023
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.023
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.023
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.023
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.022
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.022
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.022
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.022
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.022
|
|
|
|
negative regulation of cytosolic calcium ion concentration
|
GO:0051481 |
2 |
0.022
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.022
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.022
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.022
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.022
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.022
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.021
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.021
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.021
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.021
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.021
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.021
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.021
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.021
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.021
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.021
|
|
|
|
positive regulation of cation channel activity
|
GO:2001259 |
8 |
0.021
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.021
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.021
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.021
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.021
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.020
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.020
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.020
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.020
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.020
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.020
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.020
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.020
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.019
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.019
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.019
|
|
|
|
positive regulation of sodium ion transmembrane transport
|
GO:1902307 |
4 |
0.019
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.019
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.019
|
|
|
|
negative regulation of glycolytic process
|
GO:0045820 |
4 |
0.019
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.019
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.019
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.019
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.019
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.019
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.019
|
|
|
|
regulation of glutamate receptor signaling pathway
|
GO:1900449 |
16 |
0.019
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.019
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.019
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.018
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.018
|
|
|
|
ribonucleoside monophosphate biosynthetic process
|
GO:0009156 |
9 |
0.018
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.018
|
|
|
|
acetylcholine transport
|
GO:0015870 |
2 |
0.018
|
|
|
|
regulation of dephosphorylation
|
GO:0035303 |
18 |
0.018
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.018
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.018
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.018
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.018
|
|
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.018
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.018
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.018
|
|
|
|
regulation of skeletal muscle contraction by calcium ion signaling
|
GO:0014722 |
3 |
0.018
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.018
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.017
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.017
|
|
|
|
telomere maintenance
|
GO:0000723 |
19 |
0.017
|
|
|
|
regulation of intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:1902253 |
13 |
0.017
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.017
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.017
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.017
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.017
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.017
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.017
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.017
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.017
|
|
|
|
glycolytic process
|
GO:0006096 |
20 |
0.017
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.017
|
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.017
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.017
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
40 |
0.017
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.017
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.017
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.017
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.017
|
|
|
|
positive regulation of mitochondrial calcium ion concentration
|
GO:0051561 |
3 |
0.017
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.017
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.017
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.017
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.017
|
|
|
|
cardiac conduction
|
GO:0061337 |
17 |
0.016
|
|
|
|
mitochondrial rna metabolic process
|
GO:0000959 |
7 |
0.016
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.016
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.016
|
|
|
|
negative regulation of protein complex disassembly
|
GO:0043242 |
22 |
0.016
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.016
|
|
|
|
regulation of alkaline phosphatase activity
|
GO:0010692 |
6 |
0.016
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.016
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.016
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.016
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.016
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.016
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.016
|
|
|
|
positive regulation of striated muscle contraction
|
GO:0045989 |
3 |
0.016
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.016
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.016
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.016
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.016
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.016
|
|
|
|
regulation of calcium ion transmembrane transport
|
GO:1903169 |
20 |
0.016
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.016
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
11 |
0.015
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.015
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.015
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.015
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.015
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.015
|
|
|
|
telomere maintenance via telomerase
|
GO:0007004 |
1 |
0.015
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.015
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.015
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.015
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.015
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.015
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.015
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.015
|
|
|
|
positive regulation of bone remodeling
|
GO:0046852 |
13 |
0.015
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.015
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.015
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
18 |
0.014
|
|
|
|
negative regulation of b cell receptor signaling pathway
|
GO:0050859 |
4 |
0.014
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.014
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.014
|
|
|
|
negative regulation of protein depolymerization
|
GO:1901880 |
21 |
0.014
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.014
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
1 |
0.014
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.014
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.014
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.014
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.014
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.014
|
|
|
|
ribonucleoside biosynthetic process
|
GO:0042455 |
21 |
0.014
|
|
|
|
cellular response to salt stress
|
GO:0071472 |
1 |
0.014
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.014
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.014
|
|
|
|
membrane depolarization during sa node cell action potential
|
GO:0086046 |
2 |
0.014
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.014
|
|